| Literature DB >> 28944452 |
Siqi Guo1, Yu Jing1, Niculina I Burcus1, Brittany P Lassiter1, Royena Tanaz1, Richard Heller1, Stephen J Beebe1.
Abstract
Nano-pulse stimulation (NPS) as a developing technology has been studied for minimally invasive, nonthermal local cancer elimination for more than a decade. Here we show that a single NPS treatment results in complete regression of the poorly immunogenic, metastatic 4T1-Luc mouse mammary carcinoma. Impressively, spontaneous distant organ metastases were largely prevented, even in those animals with incomplete tumor regression. All tumor-free mice were protected from secondary tumor cell challenge, demonstrating a vaccine-like effect. NPS treatment induced antitumor immunity, long-term memory T cells, destruction of tumor microenvironment and reversal of the massive increase of immune suppressor cells in the tumor microenvironment and blood. NPS-treated 4T1 cells exhibited release of damage-associated molecular patterns (DAMPs), including calreticulin, HMGB1 and ATP, and activated dendritic cells. Those findings suggest that NPS is a potent immunogenic cell death inducer that elicits antitumor immunity to prevent distant metastases in addition to local tumor eradication.Entities:
Keywords: breast cancer; dendritic cell activation; immune response; immunogenic cell death; nano-pulse stimulation; tumor ablation
Mesh:
Year: 2017 PMID: 28944452 DOI: 10.1002/ijc.31071
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396